Low incidence of human papillomavirus type 16 antibody seroconversion in young children

Pediatric Infectious Disease Journal

Volumn 18, Issue 9, 1999, Pages 833-835

  Manns, Angela ^a   Strickler, Howard D ^a,d   Wiktor, Stefan Z ^a,e   Pate, Ernest J ^b,f   Gray, Robert ^b   Waters, David ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF THE WEST INDIES   (Jamaica)

^c SAIC FREDERICK INC   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e Project RETRO CI Abidjan   (Côte d’Ivoire)

^f PAN AMERICAN HEALTH ORGANIZATION   (United States)

Author keywords

Antibodies; Children; Human papillomavirus; Human papillomavirus type 16; Seroconversion; Vertical transmission

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA;

ADULT; ANTIBODY RESPONSE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; UTERINE CERVIX CANCER; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS INFECTION; VIRUS TRANSMISSION; WART VIRUS;

ADULT; ANTIBODIES, VIRAL; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TUMOR VIRUS INFECTIONS;

EID: 0032869859     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199909000-00020     Document Type: Article

References (11)

1. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
2. Sherman ME, Schiffman MH, Strickler H, Hildesheim A. Prospects for a prophylactic HPV vaccine: rationale and future implications for cervical cancer screening. Diagn Cytopathol 1998;18:5-9.
3. Strickler HD, Kirk GD, Figueroa JP, et al. HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates. Int J Cancer 1999;80: 339-44.
4. Wiktor SZ, Pate EJ, Rosenberg PS, et al. Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast feeding. J Hum Virol 1997; 1:38-45.
5. Watts DH, Koutsky LA, Holmes KK, et al. Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol 1998; 178:365-73.
6. Koch A, Hansen SV, Nielsen NM, Palefsky J, Melbye M. HPV detection in children prior to sexual debut. Int J Cancer 1997;73:621-4.
7. Viscidi RP, Kotloff KL, Clayman B, et al. Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women. Clin Diagn Lab Immunol 1997;4:122-6.
8. Sedlacek TV, Lindheim S, Eder C, et al. Mechanism for human papillomavirus transmission at birth. Am J Obstet Gynecol 1989;161:55-9.
9. Armbruster-Moraes E, Ioshimoto LM, Leao E, Zugaib M. Detection of human papillomavirus deoxyribonucleic acid sequences in amniotic fluid during different periods of pregnancy. Am J Obstet Gynecol 1993;169:1074-5.
10. Ferenczy A, Bergeron C, Rushart RM. Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections. Obstet Gynecol 1989;74:950-4.
11. Andersson-Ellstrom A, Killner J, Hagmar B, et al. Comparison of development of serum antibodies to HPV 16 and HPV 33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. Sex Transm Dis 1996; 23:234-8.